4th Quarter - Report
DOW LOHNES GOVERNMENT STRATEGIES LLC for AMGEN, INC.
Client
Income
$20,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 1427 - Promoting Innovation and Access to Life Saving Medicine Act, H.R. 1548 - Pathway for Biosimilar Act, H.R. 3962 - Affordable Health Care for America Act (provisions related to biosimilars).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC S KESSLER | Chief of Staff, Hon. John D. Dingell |
| PETE LEON | Legislative Director, Hon. Eliot Engel |
Medicare/Medicaid MMM
Medicare coverage and reimbursement, including H.R. 1894, H.R. 3962 - Affordable Health Care for America Act, and related legislation (provisions related to Medicare coverage and reimbursement for DXA testing).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC S KESSLER | Chief of Staff, Hon. John D. Dingell |
| PETE LEON | Legislative Director, Hon. Eliot Engel |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.